Quantitative systems pharmacology model of B cell immune response in mouse
Open Access
- 30 April 2026
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 17, 1745710
Abstract
B cell-mediated immunity plays a crucial role in long-term humoral protection. However, dysregulation of B cell development and differentiation may lead to the persistence of autoreactive clones, contributing to autoimmune diseases. Despite a number of therapeutic agents in preclinical and clinical development targeting B cell biology, several challenges still limit their successful translation into clinical use. To better understand B cell-targeting mechanisms of action quantitatively and mechanistically, we developed an integrative systems pharmacology model that describes T cell-dependent B cell response to antigen exposure in mouse. The model includes 20 ordinary differential equations representing key biological processes involved in the B lymphocyte response: B cell activation in secondary lymphoid organs; antibody-secreting cell (ASC) generation; migration to the bone marrow; and redistribution to peripheral tissues. The model adequately described ASC dynamics across tissues and IgG time profiles in plasma. Local and global sensitivity analyses identified the ASC production rate as the main contributor to cell counts in the spleen and in lymph nodes, while ASC levels in the bone marrow were primarily controlled by their influx rate, reflecting survival niche availability. Moderate variations of this influx rate parameter allowed the model to capture high inter-study variability in bone marrow ASC levels, explaining the observed heterogeneity in the functional immune response. The model can be further used as a quantitative tool to study B cell responses and their dysregulation in autoimmunity. It can be extended by integrating plasma-cell biology and autoantibody production, ultimately supporting the development of new therapeutic strategies for autoimmune diseases.Keywords
This publication has 120 references indexed in Scilit:
- Scientific and regulatory evaluation of mechanistic in silico drug and disease models in drug development: Building model credibilityCPT: Pharmacometrics & Systems Pharmacology, 2021
- Applications of Quantitative Systems Pharmacology in Model‐Informed Drug Discovery: Perspective on Impact and OpportunitiesCPT: Pharmacometrics & Systems Pharmacology, 2019
- Plasma cells: The programming of an antibody‐secreting machineEuropean Journal of Immunology, 2018
- How Do We “Validate” a QSP Model?CPT: Pharmacometrics & Systems Pharmacology, 2018
- Methodologies for Quantitative Systems Pharmacology (QSP) Models: Design and EstimationCPT: Pharmacometrics & Systems Pharmacology, 2017
- Model Evaluation of Continuous Data Pharmacometric Models: Metrics and GraphicsCPT: Pharmacometrics & Systems Pharmacology, 2016
- Static and dynamic components synergize to form a stable survival niche for bone marrow plasma cellsEuropean Journal of Immunology, 2014
- Tracking plasma cell differentiation and survivalCytometry Part A, 2013
- Moving from Basic Toward Systems Pharmacodynamic ModelsJournal of Pharmaceutical Sciences, 2013
- The half-lives of serum immunoglobulins in adult miceEuropean Journal of Immunology, 1988